Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASEP Medical HoldingsXCNQ:ASEP 19 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, ASEP Medical Holdings ranks better than 98.15% on this metric.
The historical rank and industry rank for ASEP Medical Holdings's Days Payable or its related term are showing as below:
XCNQ:ASEP'
s Days Payable Range Over the Past 10 Years
Min: 791.23 Med: 2895.36 Max: 87736.87
Current: 87736.87
During the past 5 years, ASEP Medical Holdings's highest Days Payable was 87736.87. The lowest was 791.23. And the median was 2895.36.
XCNQ:ASEP's Days Payable is ranked better than 98.15% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs XCNQ:ASEP: 87736.87
ASEP Medical Holdings's Days Payable
declined
from Mar. 2025 (232,733.13) to Mar. 2026 (0.00).
It may suggest that ASEP Medical Holdingsaccelerated paying its suppliers.
ASEP Medical Holdings Days Payable Related Terms
ASEP Medical Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for ASEP Medical Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:ASEP vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, ASEP Medical Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
ASEP Medical Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (XCNQ:ASEP) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ASEP Medical Holdings and its competitors. Over the past decade, ASEP Medical Holdings' Days Payable has ranged from 791.23 to 87,736.87. According to the industry distribution chart, ASEP Medical Holdings ranks #13 out of 702 companies in the Biotechnology industry, placing it in the top 1.9%.
Is ASEP Medical Holdings' Days Payable too high?
ASEP Medical Holdings' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 791.23 to a high of 87,736.87. Based on the distribution chart, ASEP Medical Holdings ranks #13 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #13 out of 702 companies for Days Payable. This places ASEP Medical Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.10. Historically, ASEP Medical Holdings' own Days Payable has ranged from 791.23 to 87,736.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ASEP Medical Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASEP Medical Holdings's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current Days Payable of 0.00. The current Days Payable is 0.00. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score
Get the complete analysis for XCNQ:ASEP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:ASEP has been successfully added to your 
